Navigation Links
Walking not enough for significant exercise benefits

Walking is a popular form of exercise, but may not be enough to experience significant health benefits, a University of Alberta study shows.

"Generally, low-intensity activity such as walking alone is not likely going to give anybody marked health benefits compared to programs that occasionally elevate the intensity," said Dr. Vicki Harber, lead author on the Health First study, which was presented recently at the American College of Sports Medicine annual conference.

Dr. Harber and her colleagues, Dr. Wendy Rodgers, Dr. Gordon Bell and Dr. Kerry Courneya of the Faculty of Physical Education and Recreation at the University of Alberta in Edmonton, Canada, were concerned that while people with health issues are encouraged to increase their volume of activity such as walking, there didn't seem to be much focus on the effort that needed to go into the activity.

The University of Alberta study put the popularized pedometer-friendly 10,000-step exercise program to the test against a traditional fitness program which incorporated cardio-based activities on equipment such as treadmills and stationary bicycles. The traditional group was asked to complete exercise at a moderate intensity, a level allowing for one or two sentences of conversation with ease. Intensity was not set for the walking group; they completed their daily exercise at a self-selected pace.

"When we matched the two programs for energy expenditure, we found that the traditional fitness program improved aerobic fitness and reduced systolic blood pressure, more than the 10,000-step lifestyle program," Dr. Harber said. Of the 128 sedentary men and women who completed the six-month research program, those who took part in a more active traditional fitness regimen increased their peak oxygen uptake, an indicator of aerobic fitness, by 10 per cent. Those who took part in the walking program experienced a four per cent increase. Systolic blood pressure also dropped by 10 per cent fo
'"/>

Source:University of Alberta


Page: 1 2

Related biology news :

1. Walking molecule now carries packages
2. Gene therapy to lower blood pressure just enough
3. A little telomerase isnt enough
4. Medical experts: US unlikely to have enough vaccines to stop avian flu
5. Heart has enough oxygen to survive hypothermia, CPR crucial
6. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
7. Increase in drug development for killer diseases is not enough
8. Mitochondrial DNA mutations play significant role in prostate cancer
9. A slight difference and significant similarities
10. Sleeping beauty plays a significant role in identifying cancer genes
11. Progress on HIV/AIDS significant but insufficient

Post Your Comments:
(Date:11/9/2009)... Naturwissenschaften is publishing a special issu...ology" to commemorate Darwin,s On the Origin of Sp...r 1859. Guest editor and author of the lead articl...iology and evolutionary biology at the University ... issue are available free of charge until 30 Decem...
(Date:11/9/2009)..., November 09, 2009 / b3c newswire / - Today, T...venth Wave, an American organization for contract ...ies have signed a letter of intent with regard to ...M. The letter of intent proposes a collaboration i...or commercialization in North America. The TIM sys...
(Date:11/8/2009)...d. - Researchers at Purdue University have discove...ers in spinal cord injuries using nano-spheres tha...n accident. , The synthetic "copolymer micelles"...diameter, or roughly 100 times smaller than the di...een studying how to deliver drugs for cancer treat...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3AcelRx Announces Perfect Performance of Handheld Component of ARX 01 Sufentanil NanoTab PCA System in a Phase 2 Study 52359 1AcelRx Announces Perfect Performance of Handheld Component of ARX 01 Sufentanil NanoTab PCA System in a Phase 2 Study 52359 2AcelRx Announces Perfect Performance of Handheld Component of ARX 01 Sufentanil NanoTab PCA System in a Phase 2 Study 52359 3Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 1Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 2Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 3Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 4Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 5Human Genome Sciences Announces New Order for Raxibacumab 28ABthrax 28TM 29 29 from U S Government 13137 6Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28 2009 13135 1Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28 2009 13135 2
... nutritious and tasty, but don’t count on them to ...er Epidemiology, Biomarkers & Prevention, rese... Fred Hutchinson Cancer Research Center report tha...tomatoes, does not effectively prevent prostate ca...on between beta-carotene, an antioxidant related t...
... Universitat Autònoma de Barcelona (UAB), in coope...-chemical biosensor which detects the presence, in...he most widely used herbicides in agriculture and ...vironment- as well as antibiotics in food. The bio...the expensive laboratory methods which are used to...
...ar symmetrical at first glance, but we,re full of ... up a pencil or throw a baseball, to where languag... our internal organs, humans are a glut of asymmet...norhabditis elegans has nerves on its left and rig...ndedness, the determination of which nerves develo...
Other Biology News:No magic tomato? Study breaks link between lycopene and prostate cancer prevention 2A new portable biosensor detects traces of contaminants in food more quickly and cheaply 2Left-right wiring determined by neural communication in the embryonic worm 2
(Date:11/6/2009)... CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolyti...s" or the "Company") today announced updated resul...) in patients with sarcomas metastatic to the lung...ctive Tissue Oncology Society Meeting held in Miam...ster presentation, entitled "A Phase II Study of I...
(Date:11/6/2009)... The agenda for Arrowhead&rsqu...ence, which is set to take place on February 22-24...s three day conference we will highlight key issue...kers to share their experiences. , ... -- The agenda for Arrowhead’s 2010 Persona...
(Date:11/5/2009)... GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ ...ts financial results for the third quarter ended S...3.6 million ($0.04 per share) for the three months...f $6.8 million ($0.08 per share) in the comparable...ber 30, 2009, GenVec,s net loss was $14.1 million ...
(Date:11/5/2009)... PARSIPPANY, N.J., Nov. 5 DSM Phar...de a manufacturing alliance with Galenix, Saint Je...d commercial scale manufacturing partner for Galen...M and Galenix will collaborate on business develop...ery technologies, based on the strength of Galenix...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
... Calif., July 31 Alsius Corporation,(Nasdaq: ALU...ture,management (IVTM(TM)) therapies for criticall...a conference call to discuss the Company,s,second ...ll Worthen,president and CEO, will host the call b...ern Time) on Thursday, August 7. A press release f...
... Colo., July 31 Sierra Neuropharmaceuticals,Inc.,...-brain treatment of,neurological diseases, announc...ing. Co-leads in the funding were HealthCare Ventu...tners. Other investors include High Country,Ventur...etary drug development process that makes use of,s...
...OWN, Pa., July 31 The Quigley,Corporation (Nasdaq...,operations of $2.1 million, for the second quarte...orted for the second quarter ended June 30,2007. F...ere $7.4 million,compared to $8.4 million reported...t sales were influenced by distribution changes an...
Other Biology Technology:Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7 2Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round 2Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 2The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 4The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 5The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 6
Rabbit Anti-Human DNase II Polyclonal Antibody, Unconjugated from Calbiochem
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
Biology Products: